Skip to main content

Table 2 Body weight change, food intake, and feeding efficiency ratio (FER) of rats fed HC diets and treated with separate and combined doses of β-conglycinin, fenofibrate and rosuvastatin.

From: β-conglycinin combined with fenofibrate or rosuvastatin have exerted distinct hypocholesterolemic effects in rats

 

Dietary groups1

 

HC

HC+7S

HC+FF

HC+RO

HC+7S+FF

HC+7S+RO

Initial weight (g/rat)

196.55 ± 4.63

195.26 ± 3.64

193.26 ± 3.64

193.33 ± 2.27

193.18 ± 3.62

194.22 ± 3.14

Final weight (g/rat)

295.01 ± 5.43

300.64 ± 7.71

281.14 ± 4.25

306.11 ± 3.79

306.64 ± 7.71

284.33 ± 8.01

Weight gain (g/rat/day)

3.51 ± 0.32

3.76 ± 0.29

3.14 ± 0.29

4.02 ± 0.16

4.05 ± 0.17

3.22 ± 0.28

Food intake (g/rat/day)

16.74 ± 0.33

16.25 ± 0.22

16.25 ± 0.22

18.20 ± 0.17**

15.61 ± 0.30

17.68 ± 0.25

Fecal excretion (g/rat/day)

3.59 ± 0.12

2.94 ± 0.09*

2.94 ± 0.09*

2.05 ± 0.12**

2.83 ± 0.09*

1.77 ± 0.13**

Feeding efficiency (%)

21.01 ± 1.44

23.05 ± 1.93

23.21 ± 1.93

21.35 ± 0.85

20.90 ± 1.51

18.25 ± 1.34

  1. 1Values are means ± SEM for nine rats. *p < 0.05 and **p < 0.001 by the Bonferroni t-test for multiple comparisons versus control group (HC). HC = hypercholesterolemic diet; HC+7S = HC diet + β-conglycinin 300 mg/kg/day; HC+FF = HC diet + fenofibrate 30 mg/kg/day; HC+RO = HC diet + rosuvastatin 10 mg/Kg/day; HC+7S+FF = HC diet + β-conglycinin + fenofibrate, 300 and 30 mg/kg/day respectively, and HC+7S+RO = HC diet + β-conglycinin + rosuvastatin, 300 and 10 mg/kg/day respectively.